1. Introduction
Colorectal cancer (CRC) constitutes a noticeable global public health burden, as it is the third most common and second most deadly type of cancer worldwide, with an estimated incidence of approximately 1.9 million cases in 2020 [ 1 ]. The number of cases of CRC is also escalating in many Asian countries including South Korea, which is partially influenced by a westernized diet, reduced physical activity, alcohol consumption, and increased body mass index (BMI) [ 2 ]. Currently, CRC is the second leading cancer in Korea and ranks third highest with respect to the number of deaths caused due to cancer [ 3 , 4 ]. In response to the increasing burden of cancer, Korea has implemented a national cancer screening program that includes CRC as one of its target cancer types. This has contributed to early detection of CRC in the Korean population [ 5 ]. Yet, the burden of CRC persists. Furthermore, as Korea is an aging country, constant monitoring is required. CRC is often reported as a disease of the elderly, and age is regarded as a major risk factor [ 2 , 6 ].
Understanding patterns of cancer mortality can provide an insight into the effect of cancer on population health, and has hence been mostly well documented. However, knowledge regarding differences in mortality in CRC patients with disability is largely deficient despite disabled individuals representing a major group of vulnerable populations, given that approximately 15% of the global population has disabilities [ 7 ]. The number of people with disabilities has also increased in Korea from approximately 2.1 million in 2005 to 2.7 million in 2017 [ 8 ]. Investigating mortality in cancer patients with disability is important because cancer is usually detected at a later stage in such populations and patients show poorer survival [ 9 , 10 ]. Individuals with disabilities are known to experience various barriers, including physical and communicational constraints, in accessing and utilizing healthcare [ 11 , 12 , 13 ]. People with disabilities also often have lower education or income, which may lead to further disparities in cancer diagnosis, treatment, and prognosis [ 9 , 14 ].
Disability not only impedes independence but also increases dependence on family or social support for survival, which leads to an increased social burden and a decreased quality of life, especially in the elderly. Therefore, investigating potential differences in mortality according to disability status in older patients with CRC [ 15 ] is required. The objective of this study was to examine the association of disability status with overall and 5-year all-cause mortality in patients with CRC aged 60 years or above. The hypothesis was that CRC patients with disabilities would have a higher risk of mortality than those without disabilities. Additional subgroup analysis was conducted based on disability severity.
2. Methods
2.1. Data and Study Population
This study used data from the 2008–2019 National Health Insurance Service (NHIS) senior cohort. This cohort includes claims data from approximately 8% of the entire population aged from 60 to 80 years in 2008 that was selected through random sampling after stratification based on sex, age, the level of health insurance premium, and region [ 16 ]. The study population consisted of individuals who were first diagnosed with CRC (International Classification of Diseases [ICD]-10: C18–C21) at age 60 years or above (N = 11,496). Subsequently, 5156 individuals who did not receive any type of treatment for CRC within 6 months of cancer diagnosis or who died within 1 month of cancer diagnosis were excluded. The final study population consisted of 6340 participants.
2.2. Variables
The outcome measures of this study were all-cause 5-year and overall mortality. The dates listed for diagnosis of CRC and issuance of the cancer-specific insurance claims code were used to set the index date. Study participants were categorized based on their overall and 5-year survival status after diagnosis.
The primary independent variable was disability status, which was categorized based on the Certificate of Person with Disability distributed by the government [ 17 ]. Individuals can be registered as persons with disability after applying and undergoing an examination. Both physical and mental disabilities are included, namely physical impairment, brain impairment, visual impairment, hearing impairment, linguistic impairment, mental impairment, developmental disability, and others (impairment due to renal functioning, heart functioning, respiratory functioning, liver functioning, intestinal functioning, or urinal tract functioning, epilepsy, and facial disfigurement). The severity of disabilities was classified based on the standard used by the disability registration system in Korea, in which the severity of disability ranges from grades one to six, wherein grades one to three are classified as severe disability and four to six as mild disability [ 18 ]. The category of mild disability includes individuals who can perform some level of daily tasks with the use of partial personal assistance of assistive devices whereas severe disability refers to those who require heavy dependence on personal assistance or assistive devices [ 19 ].
Various covariates were included in the analysis, such as sex (male or female), age (60–69, 70–79, or 80+ years), income (quartiles), type of healthcare insurance (medical aid, NHI self-employed, or NHI employee), region (urban or rural), chronic diseases (none or 1+), level of comorbidity, type of cancer treatment (surgery only, surgery plus chemotherapy or radiotherapy, or surgery plus both chemotherapy and radiotherapy), and type of hospital (tertiary or general hospital). Chronic diseases referred to the presence of diabetes, hypertension, or dyslipidemia that were identified based on ICD-10 codes E10-E14, I10-I15, and E78. The level of comorbidity was measured using the Charlson Comorbidity Index (CCI), which was scored after excluding cancer. The composite CCI score was obtained by summing the weighted score of 17 comorbidities and indicates the level of disease burden [ 20 ].
2.3. Statistical Analysis
The general characteristics of the study population were examined based on the chi-square test. Kaplan–Meier survival curves and log-rank tests performed based on disability status were used to compare survival time. Proportional hazard assumption was also tested through the Kaplan–Meier survival curve. Survival analysis using the Cox proportional hazards model for overall and 5-year mortality were also conducted after adjusting for all the covariates. Results were expressed in hazard ratios (HR) and their 95 percent confidence intervals (95% CI). Additional subgroup analysis was performed based on disability severity. P-values were two-sided and considered significant at <0.05. All survival analyses were conducted as multivariate analysis after adjusting for all covariates. All statistical analyses were executed using the SAS statistical software, version 9.4 (Cary, NC, USA).
3. Results
General characteristics of the study population are presented in Table 1 . From 6340 patients with CRC aged 60 years or above, 1733 (27.3%) individuals died within five years of cancer diagnosis and 2334 (36.8%) individuals died within the entire study period. Disability was found in 999 individuals, which accounted for approximately 15.8% of the entire study population. Both 5-year (32.8%) and overall mortality (42.0%) were more frequent in participants with disability.
The results of the survival analysis regarding the association between all-cause mortality and disability status are shown in Table 2 . Kaplan–Meier survival curves between those with and without disability are found in Figure 1 . Participants with disability had a higher risk of both all-cause 5-year (hazard ratio [HR] 1.21, 95% confidence interval [95% CI] 1.07–1.37) and overall mortality (HR 1.15, 95% CI 1.03–1.28). Results of the subgroup analysis based on the severity level of disability are revealed in Table 3 and Figure 2 . Tendencies found in the main findings were maintained regardless of the severity of disability, as patients with disability tended to have higher overall and 5-year all-cause mortality. Specifically, these tendencies were particularly pronounced in individuals with severe (5-year mortality: HR 1.58, 95% CI 1.29–1.93; overall mortality: HR 1.48, 95% CI 1.24–1.76) rather than mild (five-year mortality: HR 1.09, 95% CI 0.95–1.26; overall mortality: HR 1.05, 95% CI 0.92–1.19) disability.
4. Discussion
This study investigated the effect of disability status on all-cause mortality in patients with CRC aged 60 years or above using nationwide data from Korea. The results revealed that the percentage of individuals who survived overall and for 5 years was higher in cancer patients without disabilities, as compared to those with disabilities. Likewise, older CRC patients with disability also showed a higher risk of overall and 5-year all-cause mortality compared to those without disability. These tendencies were particularly significant in study participants with severe disability. Our findings provide further evidence that disparities in mortality may exist according to disability status in older patients with CRC, although the fact that individuals with disabilities tend to have a generally shorter life expectancy than those without disabilities should be concurrently taken into consideration when interpreting the study results [ 21 ].
The study results are in accordance with a previous study, which revealed that cancer patients with disabilities tended to have higher mortality compared to cancer patients without disabilities [ 22 ]. For instance, a study regarding Medicare beneficiaries in the United States concluded that disabled beneficiaries diagnosed with breast cancer and CRC had higher overall and cancer-specific mortality. A study of the Dutch adult population also found that cancer-related mortality was more common in individuals with intellectual disability [ 10 ]. Likewise, a previous study in Korea reported that cancer patients with disabilities had higher long-term all-cause mortality, and that such propensities also tended to persist in 5-year cancer survivors, suggesting the need for further collaborative efforts to improve the survival of cancer patients and survivors [ 23 ]. Another study similarly demonstrated a higher risk of overall mortality in cervical cancer patients with disabilities and concluded that social support and policies were needed to improve such disparities [ 24 ]. Lower survival rates were also found in disabled individuals diagnosed with multiple myeloma compared to their non-disabled counterparts [ 25 ].
The excessive number of deaths in CRC patients with disabilities may, in part, be because those with disabilities generally have higher comorbidities and face poorer socioeconomic conditions [ 9 ]. Complex health conditions underlying certain types of disabilities, combined with the side effects of cancer treatment, may have led to a higher risk of mortality in cancer patients with disabilities [ 26 ]. Treatment options for cancer may also be comparatively limited for some patients with disabilities for several reasons, which include difficulties in easily accessing transportation on a daily basis to receive treatment in healthcare institutions [ 27 ]. Further, medical institutions may also lack various facilities that allow easy access for patients with disabilities [ 28 ]. Patients with disabilities are often less likely to receive treatment for cancer, which may be partially influenced by some medical professionals discouraging treatment or the disabled individuals deciding to give up treatment because of an underestimation of the benefits of treatment or an overestimation of the possibility of treatment-related complications [ 29 ].
This study had some limitations. First, cancer severity, including the stage of cancer at diagnosis or pathologic test results, could not be accounted for because of data limitations. However, the analysis excluded individuals who died within 1 month of diagnosis or those who were not hospitalized to receive treatment for cancer in order to enhance homogeneity of the study population. Second, information regarding certain characteristics that may have been important in evaluating mortality after treatment, such as adherence to postoperative care or suitability of the type of oncologic treatment received, were unavailable. Third, this study only considered overall mortality, but not cancer-specific mortality, as its outcomes were variable owing to the limitations in available data. Future studies examining cancer-specific mortality in CRC patients with disabilities are required to develop further understanding in this regard. Last, it has been previously reported that people with disabilities tend to have a shorter life expectancy than the general population and such tendencies may be comparatively pronounced in older individuals [ 29 ]. This study only investigated the effect of disabilities on all-cause mortality in patients with CRC. Further studies examining the synergistic effect between disability and CRC on mortality compared to non-disabled individuals are needed to gain further insights. The findings emphasize the importance of developing and strengthening healthcare policies that can reduce disparities in mortality of cancer patients according to their disability status, particularly in older individuals, as many countries face an aging population and cancer occurrence is known to increase with age.
5. Conclusions
Patients with CRC aged 60 years or above with disabilities, particularly severe disabilities, showed a higher risk of overall and 5-year all-cause mortality than those without disabilities. The findings reveal the existence of disparities in survival rates according to disability status in older patients with CRC. Efforts are needed to strengthen healthcare policies and guidelines that can reduce disability-related disparities found in this study.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Author Contributions
Conceptualization, W.-R.L., K.-T.H. and W.K.; data curation, W.-R.L., M.C. and K.-T.H.; methodology, W.-R.L., K.-T.H., M.C. and W.K.; formal analysis, W.-R.L. and K.-T.H.; writing—original draft, W.K.; writing—review and editing, W.-R.L., K.-T.H., M.C. and W.K. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was waived for this study by the Institutional Review Board of the National Cancer Center, Korea (NCC2022-0249), as it used only secondary data in which all personal information was anonymized and encrypted.
Informed Consent Statement
This study only used secondary data in which all personal information was anonymized and encrypted.
Data Availability Statement
Data can be obtained for research purposes after application to the National Health Insurance Service.
Conflicts of Interest
The authors have no relevant financial or non-financial conflicts of interest to disclose.
References
1. Xi Y. Xu P. Global colorectal cancer burden in 2020 and projections to 2040 Transl. Oncol. 2021 14 101174 10.1016/j.tranon.2021.101174 34243011 PMC8273208
2. Baek S.K. Lee J.S. Hwang I.G. Kim J.G. Kim T.W. Sohn S.K. Kang M.Y. Lee S.-C. Clinical characteristics and survival of colorectal cancer patients in Korea stratified by age Korean J. Intern. Med. 2021 36 985 991 10.3904/kjim.2019.066 33820397 PMC8273826
3. Keum N. Giovannucci E. Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies Nat. Rev. Gastroenterol. Hepatol. 2019 16 713 732 10.1038/s41575-019-0189-8 31455888
4. Hong S. Won Y.J. Park Y.R. Jung K.W. Kong H.J. Lee E.S. Community of Population-Based Regional Cancer Registries Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017 Cancer Res. Treat. 2020 52 335 350 10.4143/crt.2020.206 32178489 PMC7176962
5. Park B. Lee Y.Y. Song S.Y. Shin H.Y. Suh M. Choi K.S. Jun J.K. Trends of Colorectal Cancer Screening Rates in Korea: Korean National Cancer Screening Survey 2005–2020 Gut Liver. 2022 Online ahead of print 10.5009/gnl210419 PMC9668502 35466090
6. Balducci L. Management of cancer in the elderly Oncology (Williston Park). 2006 20 135 143 discussion 144, 146, 51–52 16562648
7. World Health Organization (WHO) World Report on Disability WHO Geneva, Switzerland 2018
8. Kim S.H. Lee Y.H. Oh W.C. Hwang J.H. Oh M.A. Lee N.H. Oh D.E. Kang D.W. Kwon S.J. Oh G.K. 2017 Survey on the Actual Condition of the Disabled Korea Ministry of Health and Welfare, Korea Institute for Health and Social Affairs Seoul, Korea 2017
9. Kim H.W. Shin D.W. Yeob K.E. Cho I.Y. Kim S.Y. Park S.M. Park J.H. Park J.H. Kawachi I. Disparities in the Diagnosis and Treatment of Gastric Cancer in Relation to Disabilities Clin. Transl. Gastroenterol. 2020 11 e00242 10.14309/ctg.0000000000000242 33108122 PMC7544185
10. Cuypers M. Schalk B. Boonman A. Naaldenberg J. Leusink G. Cancer-related mortality among people with intellectual disabilities: A nationwide population-based cohort study Cancer 2022 128 1267 1274 10.1002/cncr.34030 34787906 PMC9299498
11. Kroll T. Jones G.C. Kehn M. Neri M.T. Barriers and strategies affecting the utilisation of primary preventive services for people with physical disabilities: A qualitative inquiry Health Soc. Care Community 2006 14 284 293 10.1111/j.1365-2524.2006.00613.x 16787479
12. Horner-Johnson W. Dobbertin K. Lee J.C. Andresen E.M. Expert Panel on Disability and Health Disparities Disparities in health care access and receipt of preventive services by disability type: Analysis of the medical expenditure panel survey Health Serv. Res. 2014 49 1980 1999 10.1111/1475-6773.12195 24962662 PMC4254135
13. Deroche C.B. McDermott S.W. Mann J.R. Hardin J.W. Colorectal Cancer Screening Adherence in Selected Disabilities Over 10 Years Am. J. Prev. Med. 2017 52 735 741 10.1016/j.amepre.2017.01.005 28214250
14. Singal N. Disability, poverty and education: Implications for policies and practices Int. J. Incl. Educ. 2011 15 1047 1052 10.1080/13603116.2011.555065
15. Kim S. Kim M.-I. Han D. Incidence Rates of Disability and Its Associated Factors among Korean Community-Dwelling Older Adults Iran J. Public Health 2020 49 1718 1726 10.18502/ijph.v49i9.4091 33643947 PMC7898091
16. National Health Insurance Sharing Service Sample Research DB: Details of DB Publisher National Health Insurance Service Wonju, Korea 2022
17. Ministry of Health and Welfare Division Policy for People with Disabilities Ministry of Health and Welfare Sejong, Korea 2022
18. Jeon B. Noguchi H. Kwon S. Ito T. Tamiya N. Disability, poverty, and role of the basic livelihood security system on health services utilization among the elderly in South Korea Soc. Sci. Med. 2017 178 175 183 10.1016/j.socscimed.2017.02.013 28237862
19. Ministry of Health and Welfare The Criteria for Disability Rating [Korean] Ministry of Health and Welfare Sejong, Korea 2015
20. Sundararajan V. Henderson T. Perry C. Muggivan A. Quan H. Ghali W.A. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality J. Clin. Epidemiol. 2004 57 1288 1294 10.1016/j.jclinepi.2004.03.012 15617955
21. Bahk J. Kang H.-Y. Khang Y.-H. Disability type–specific mortality patterns and life expectancy among dis-abled people in South Korea using 10-year combined data between 2008 and 2017 Prev. Med. Rep. 2022 29 101958 10.1016/j.pmedr.2022.101958 36161125 PMC9501987
22. Reeves C. Collingridge D. Improving cancer care for people with disabilities Lancet Oncol. 2022 23 446 447 10.1016/S1470-2045(22)00147-4 35358448
23. Park S. Son K. Park J.-H. Cho B. Disparities in short-term and long-term all-cause mortality among Korean cancer patients with and without preexisting disabilities: A nationwide retrospective cohort study Support Care Cancer 2011 20 963 970 10.1007/s00520-011-1168-y 21519947
24. Choi J.Y. Yeob K.E. Hong S.H. Kim S.Y. Jeong E.H. Shin D.W. Park J.H. Kang G.W. Kim H.S. Park J.H. Disparities in the Diagnosis, Treatment, and Survival Rate of Cervical Cancer among Women with and without Disabilities Cancer Control 2021 28 10732748211055268 10.1177/10732748211055268 35042390 PMC8771753
25. Kwon J. Kim S.Y. Yeob K.E. Han H.S. Lee K.H. Shin D.W. Kim Y.Y. Park J.H. Park J.H. The Effect of Disability on the Diagnosis and Treatment of Multiple Myeloma in Korea: A National Cohort Study Cancer Res. Treat. 2020 52 1 9 10.4143/crt.2018.702 31010276 PMC6962464
26. McCarthy E.P. Ngo L.H. Chirikos T.N. Roetzheim R.G. Li D. Drews R.E. Iezzoni L.I. Cancer Stage at Diagnosis and Survival among Persons with Social Security Disability Insurance on Medicare Health Serv. Res. 2007 42 611 628 10.1111/j.1475-6773.2006.00619.x 17362209 PMC1955354
27. Park J.H. Lee J.S. Lee J.Y. Gwack J. Park J.H. Kim Y.I. Kim Y. Disparities between persons with and without disabilities in their participation rates in mass screening Eur. J. Public Health 2009 19 85 90 10.1093/eurpub/ckn108 19158103
28. Lee J.Y. Jeong J. Kim Y.K. Jun E.-K. Kim S.Y. Kim H.J. Lee B.W. Has Disabled Access in Healthcare Institutions been Increased? A Case Study of Jongno-gu in Seoul, Korea Korean J. Health Policy Adm. 2012 22 696 702 10.4332/KJHPA.2012.22.4.696
29. Shin D.W. Cho J.H. Noh J.M. Han H. Han K. Park S.H. Kim S.Y. Park J.H. Park J.H. Kawachi I. Disparities in the Diagnosis and Treatment of Lung Cancer among People with Disabilities J. Thorac. Oncol. 2019 14 163 175 10.1016/j.jtho.2018.10.158 30453082